Occupation (construction worker)
🔷 Working as a construction worker exposes the client to chronic loud noise from machinery, power tools, and heavy equipment.
🔷 Prolonged exposure to high-decibel noise is a major cause of noise-induced hearing loss, especially when hearing protection is not consistently used.
🔷 This type of occupational noise damages the hair cells in the cochlea, leading to gradual, often irreversible sensorineural hearing loss.
🔷 The client’s new symptoms of ringing in both ears (tinnitus) and difficulty hearing the television are consistent with early noise-related damage.
🔷 Therefore, the client’s occupation is a significant risk factor for hearing impairment.
Furosemide
🔷 Furosemide is a loop diuretic known to have ototoxic effects, especially at higher doses or with rapid IV administration, but risk can exist even with chronic oral use.
🔷 It can damage structures in the inner ear, particularly affecting cochlear function, leading to tinnitus and hearing loss.
🔷 Ototoxicity risk increases when loop diuretics are combined with other ototoxic agents or used long-term in vulnerable clients.
🔷 The client’s symptom of ringing in both ears is a classic sign of drug-induced ototoxicity.
🔷 Thus, furosemide is appropriately identified as a risk factor for hearing impairment.
Naproxen
🔷 Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), can cause reversible ototoxicity, including tinnitus and decreased hearing, especially with prolonged or higher-dose use.
🔷 NSAIDs can alter cochlear blood flow and affect inner ear function, contributing to sensorineural hearing changes.
🔷 The client has been taking naproxen twice daily for months, which increases the risk of auditory side effects.
🔷 The combination of ringing in both ears and documented 39 dB hearing loss is consistent with possible medication-related changes.
🔷 Therefore, naproxen is a valid risk factor for hearing impairment in this client.
Osteoarthritis
🔷 Osteoarthritis is a degenerative joint disease affecting cartilage and bones, primarily in weight-bearing joints.
🔷 It does not directly damage the auditory system, cochlea, or cranial nerve VIII.
🔷 While it may affect mobility or quality of life, it is not recognized as a primary risk factor for hearing loss.
🔷 Hearing changes in this client are more plausibly linked to ototoxic medications and noise exposure than to joint disease.
🔷 Therefore, osteoarthritis does not place the client at increased risk for hearing impairment in this context.
Hyperlipidemia
🔷 Hyperlipidemia affects blood lipid levels and is a risk factor for cardiovascular disease, but its link to hearing loss is indirect and not primary.
🔷 Some research suggests that poor vascular health might influence cochlear blood flow, but it is not considered a major standalone cause of hearing impairment in standard nursing assessments.
🔷 In this scenario, more potent and proven factors—such as noise exposure and ototoxic drugs—offer a clearer explanation.
🔷 Hyperlipidemia is more strongly associated with atherosclerosis and cardiac/cerebrovascular events rather than early tinnitus and hearing changes.
🔷 Thus, hyperlipidemia is not selected as a primary hearing risk factor here.
Lovastatin
🔷 Lovastatin is a statin used to lower cholesterol and reduce cardiovascular risk.
🔷 While statins have various side effects (e.g., muscle pain, liver enzyme elevation), they are not widely recognized as primary ototoxic agents.
🔷 Evidence linking statins to hearing loss is limited and inconsistent, especially compared to strong ototoxic drugs like loop diuretics and some NSAIDs.
🔷 In this context, lovastatin is less likely to explain the client’s tinnitus and 39 dB hearing loss.
🔷 Therefore, lovastatin is not considered a key risk factor for hearing impairment in this case.